145 related articles for article (PubMed ID: 24632718)
21. Comparison of dopamine and norepinephrine in shock.
De Santis V; Nencini C; Tritapepe L
N Engl J Med; 2010 Jun; 362(24):2329; author reply 2330-1. PubMed ID: 20560160
[No Abstract] [Full Text] [Related]
22. Acute circulatory failure secondary to myocardial infarction.
McCann WD; O'Donovan TP
Postgrad Med; 1971 May; 49(5):74-9. PubMed ID: 4325238
[No Abstract] [Full Text] [Related]
23. Treatment of shock in myocardial infarction.
Johnson SA; Gunnar RM
JAMA; 1977 May; 237(19):2106-8. PubMed ID: 576895
[No Abstract] [Full Text] [Related]
24. [High-dose nitroglycerin in cardiogenic shock].
Guglina ME
Klin Med (Mosk); 1997; 75(6):27-30. PubMed ID: 9273395
[TBL] [Abstract][Full Text] [Related]
25. The treatment of cardiogenic shock. II. The use of pressor agents in the treatment of cardiogenic shock.
Kuhn LA
Am Heart J; 1967 Nov; 74(5):725-8. PubMed ID: 6055703
[No Abstract] [Full Text] [Related]
26. [Treatment of shock in myocardial infarct with dextran and noradrenaline].
Sedziwy L
Wiad Lek; 1977 Jan; 30(1):31-5. PubMed ID: 835259
[No Abstract] [Full Text] [Related]
27. Vasopressors for hypotensive shock.
Lampard JG; Lang E
Ann Emerg Med; 2013 Mar; 61(3):351-2. PubMed ID: 23026787
[No Abstract] [Full Text] [Related]
28. Tilarginine in patients with acute myocardial infarction and cardiogenic shock.
Teerlink T
JAMA; 2007 Sep; 298(9):971-2; author reply 972-3. PubMed ID: 17785640
[No Abstract] [Full Text] [Related]
29. [Treatment of cardiogenic shock in myocardial infarct].
Smetnev AS; Petrova LI; Dobrotvorskaia TE
Ter Arkh; 1973; 45(2):95-101. PubMed ID: 4768363
[No Abstract] [Full Text] [Related]
30. Hemodynamics, coronary blood flow, and myocardial metabolism in coronary shock; response of 1-norepinephrine and isoproterenol.
Mueller H; Ayres SM; Gregory JJ; Giannelli S; Grace WJ
J Clin Invest; 1970 Oct; 49(10):1885-902. PubMed ID: 5460498
[TBL] [Abstract][Full Text] [Related]
31. Tilarginine in patients with acute myocardial infarction and cardiogenic shock.
Kielstein JT; Sydow K; Thum T
JAMA; 2007 Sep; 298(9):971; author reply 972-3. PubMed ID: 17785641
[No Abstract] [Full Text] [Related]
32. Drug therapy of cardiogenic shock.
Barrett AM
Int J Clin Pharmacol; 1973 Apr; 7(2):105-8. PubMed ID: 4731278
[No Abstract] [Full Text] [Related]
33. Vasopressor agents in shock.
Moyer JH; Mills LC
Am J Nurs; 1975 Apr; 75(4):620-5. PubMed ID: 1039254
[TBL] [Abstract][Full Text] [Related]
34. Cardiogenic shock.
Rackley CE; Russell RO; Mantle JA; Rogers WJ
Cardiovasc Clin; 1981; 11(3):15-24. PubMed ID: 7214388
[TBL] [Abstract][Full Text] [Related]
35. Cardiogenic shock: Inotropes and vasopressors.
Amado J; Gago P; Santos W; Mimoso J; de Jesus I
Rev Port Cardiol; 2016 Dec; 35(12):681-695. PubMed ID: 27836218
[TBL] [Abstract][Full Text] [Related]
36. Shock after acute myocardial infarction. A clinical and hemodynamic profile.
Scheidt S; Ascheim R; Killip T
Am J Cardiol; 1970 Dec; 26(6):556-64. PubMed ID: 5520786
[No Abstract] [Full Text] [Related]
37. [Therapy of shock during acute myocardial infarct].
Mirić V
Med Arh; 1972; 26(2):105-8. PubMed ID: 5030442
[No Abstract] [Full Text] [Related]
38. Rational therapeutic approach to cardiogenic shock.
Wiener L
Cardiovasc Clin; 1974; 6(2):223-37. PubMed ID: 4613459
[No Abstract] [Full Text] [Related]
39. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.
; Alexander JH; Reynolds HR; Stebbins AL; Dzavik V; Harrington RA; Van de Werf F; Hochman JS
JAMA; 2007 Apr; 297(15):1657-66. PubMed ID: 17387132
[TBL] [Abstract][Full Text] [Related]
40. Levosimendan as rescue therapy in severe cardiogenic shock after ST-elevation myocardial infarction.
Greif M; Zwermann L; Reithmann C; Weis M
Acute Card Care; 2008; 10(3):185-90. PubMed ID: 18972629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
